vs
Side-by-side financial comparison of Cytosorbents Corp (CTSO) and JOINT Corp (JYNT). Click either name above to swap in a different company.
JOINT Corp is the larger business by last-quarter revenue ($15.2M vs $9.2M, roughly 1.6× Cytosorbents Corp). JOINT Corp runs the higher net margin — 6.5% vs -59.5%, a 66.1% gap on every dollar of revenue. On growth, JOINT Corp posted the faster year-over-year revenue change (3.1% vs 0.9%). JOINT Corp produced more free cash flow last quarter ($334.7K vs $-4.9M). Over the past eight quarters, Cytosorbents Corp's revenue compounded faster (1.3% CAGR vs -28.6%).
CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.
The Joint Corp is a leading operator and franchisor of chiropractic care clinics primarily serving the U.S. market. It offers accessible, affordable routine chiropractic services, membership-based care plans, and caters to consumers seeking non-invasive musculoskeletal pain management and wellness support.
CTSO vs JYNT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $15.2M |
| Net Profit | $-5.5M | $991.1K |
| Gross Margin | 73.7% | 81.4% |
| Operating Margin | -47.5% | 4.9% |
| Net Margin | -59.5% | 6.5% |
| Revenue YoY | 0.9% | 3.1% |
| Net Profit YoY | 27.4% | 5510.5% |
| EPS (diluted) | $-0.09 | $0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $15.2M | ||
| Q3 25 | $9.5M | $13.4M | ||
| Q2 25 | $9.6M | $13.3M | ||
| Q1 25 | $8.7M | $13.1M | ||
| Q4 24 | $9.2M | $14.7M | ||
| Q3 24 | $8.6M | $30.2M | ||
| Q2 24 | $8.8M | $30.3M | ||
| Q1 24 | $9.0M | $29.7M |
| Q4 25 | $-5.5M | $991.1K | ||
| Q3 25 | $-3.2M | $855.0K | ||
| Q2 25 | $1.9M | $93.4K | ||
| Q1 25 | $-1.5M | $967.8K | ||
| Q4 24 | $-7.6M | $17.7K | ||
| Q3 24 | $-2.8M | $-3.2M | ||
| Q2 24 | $-4.3M | $-3.6M | ||
| Q1 24 | $-6.1M | $947.0K |
| Q4 25 | 73.7% | 81.4% | ||
| Q3 25 | 70.3% | 80.1% | ||
| Q2 25 | 70.9% | 79.1% | ||
| Q1 25 | 71.1% | 77.3% | ||
| Q4 24 | 68.4% | 78.4% | ||
| Q3 24 | 61.0% | 90.7% | ||
| Q2 24 | 73.5% | 90.7% | ||
| Q1 24 | 76.5% | 90.9% |
| Q4 25 | -47.5% | 4.9% | ||
| Q3 25 | -30.2% | 1.2% | ||
| Q2 25 | -37.6% | -8.6% | ||
| Q1 25 | -44.5% | -5.2% | ||
| Q4 24 | -37.1% | 5.5% | ||
| Q3 24 | -56.1% | -1.6% | ||
| Q2 24 | -40.4% | -5.9% | ||
| Q1 24 | -51.8% | -1.4% |
| Q4 25 | -59.5% | 6.5% | ||
| Q3 25 | -33.4% | 6.4% | ||
| Q2 25 | 20.2% | 0.7% | ||
| Q1 25 | -16.9% | 7.4% | ||
| Q4 24 | -82.7% | 0.1% | ||
| Q3 24 | -32.1% | -10.5% | ||
| Q2 24 | -48.6% | -11.9% | ||
| Q1 24 | -67.7% | 3.2% |
| Q4 25 | $-0.09 | $0.06 | ||
| Q3 25 | $-0.05 | $0.06 | ||
| Q2 25 | $0.03 | $0.01 | ||
| Q1 25 | $-0.02 | $0.06 | ||
| Q4 24 | $-0.14 | $0.01 | ||
| Q3 24 | $-0.05 | $-0.21 | ||
| Q2 24 | $-0.08 | $-0.24 | ||
| Q1 24 | $-0.11 | $0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.2M | $23.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.9M | $15.1M |
| Total Assets | $44.2M | $61.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.2M | $23.6M | ||
| Q3 25 | $7.5M | $29.7M | ||
| Q2 25 | $10.2M | $29.8M | ||
| Q1 25 | $11.6M | $21.9M | ||
| Q4 24 | $3.3M | $25.1M | ||
| Q3 24 | $5.7M | $20.7M | ||
| Q2 24 | $8.5M | $17.5M | ||
| Q1 24 | $8.6M | $18.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.8M | — | ||
| Q2 24 | $13.7M | — | ||
| Q1 24 | $4.4M | — |
| Q4 25 | $5.9M | $15.1M | ||
| Q3 25 | $9.0M | $22.7M | ||
| Q2 25 | $11.6M | $23.2M | ||
| Q1 25 | $14.5M | $22.8M | ||
| Q4 24 | $11.1M | $20.7M | ||
| Q3 24 | $13.4M | $20.5M | ||
| Q2 24 | $17.4M | $23.2M | ||
| Q1 24 | $19.6M | $26.2M |
| Q4 25 | $44.2M | $61.0M | ||
| Q3 25 | $45.8M | $69.4M | ||
| Q2 25 | $48.0M | $73.2M | ||
| Q1 25 | $50.8M | $80.1M | ||
| Q4 24 | $47.4M | $83.2M | ||
| Q3 24 | $47.8M | $79.6M | ||
| Q2 24 | $53.4M | $82.4M | ||
| Q1 24 | $47.1M | $85.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.03× | — | ||
| Q2 24 | 0.78× | — | ||
| Q1 24 | 0.23× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.8M | $1.8M |
| Free Cash FlowOCF − Capex | $-4.9M | $334.7K |
| FCF MarginFCF / Revenue | -53.4% | 2.2% |
| Capex IntensityCapex / Revenue | 1.2% | 9.9% |
| Cash ConversionOCF / Net Profit | — | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-12.5M | $-1.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.8M | $1.8M | ||
| Q3 25 | $-2.6M | $1.8M | ||
| Q2 25 | $-1.5M | $868.6K | ||
| Q1 25 | $-3.5M | $-3.7M | ||
| Q4 24 | $-2.3M | $9.4M | ||
| Q3 24 | $-2.5M | $3.4M | ||
| Q2 24 | $-4.8M | $-973.5K | ||
| Q1 24 | $-4.8M | $2.8M |
| Q4 25 | $-4.9M | $334.7K | ||
| Q3 25 | $-2.6M | $1.5M | ||
| Q2 25 | $-1.5M | $363.6K | ||
| Q1 25 | $-3.5M | $-4.0M | ||
| Q4 24 | $-2.4M | $8.2M | ||
| Q3 24 | $-2.6M | $3.2M | ||
| Q2 24 | $-4.8M | $-1.2M | ||
| Q1 24 | $-4.9M | $2.4M |
| Q4 25 | -53.4% | 2.2% | ||
| Q3 25 | -27.3% | 10.9% | ||
| Q2 25 | -16.1% | 2.7% | ||
| Q1 25 | -39.7% | -30.8% | ||
| Q4 24 | -26.3% | 55.9% | ||
| Q3 24 | -30.4% | 10.6% | ||
| Q2 24 | -54.4% | -4.1% | ||
| Q1 24 | -54.2% | 8.1% |
| Q4 25 | 1.2% | 9.9% | ||
| Q3 25 | 0.2% | 2.4% | ||
| Q2 25 | 0.4% | 3.8% | ||
| Q1 25 | 0.0% | 2.5% | ||
| Q4 24 | 0.8% | 8.1% | ||
| Q3 24 | 1.8% | 0.8% | ||
| Q2 24 | 0.2% | 0.9% | ||
| Q1 24 | 0.5% | 1.3% |
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | 2.07× | ||
| Q2 25 | -0.78× | 9.30× | ||
| Q1 25 | — | -3.82× | ||
| Q4 24 | — | 532.98× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTSO
| Direct | $5.1M | 55% |
| Distributors And Strategic Partners | $4.2M | 45% |
JYNT
| Transferred At Point In Time | $12.8M | 84% |
| Transferred Over Time | $2.4M | 16% |
